ABCG2 and acute myeloid leukemia: However, these observations did not correlate with detectable differences in either cell proliferation rates or activity of ABC transporters associated with multi-drug resistance, including P-glycoprotein 1, between AML and other tumour types (Supplementary Fig. 4).